This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Lack of Desipramine Toxicity With Citalopram

Adam Keller Ashton

Published: July 31, 2000

Article Abstract

Letter to the Editor

Sir: Selective serotonin reuptake inhibitors (SSRIs) areknown to inhibit specific human hepatic cytochrome P450(CYP) isoenzymes, which are critical in the metabolism of mostmedications. Paroxetine is thought to possess highly potentinhibiting properties for the CYP2D6 isoenzyme. CYP2D6 isthe major enzyme involved in catabolism of many commonlyused agents, including neuroleptics, antidepressants, Type ICantiarrhythmics, codeine, ß-blockers, and dextromethorphan.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...